9-Deoxo-9a-aza-9a-homo 4’-Keto Erythromycin A

9-Deoxo-9a-aza-9a-homo 4’-Keto Erythromycin A Chemische Eigenschaften,Einsatz,Produktion Methoden

• Verwenden

  2R,?3S,?4R,?5R,?8R,?10R,?11R,?12S,?13S,?14R)?-13-?[(2,?6-?Dideoxy-?3-?C-?methyl-?3-?O-?methyl-?α-?L-?erythro-?hexopyranos-?4-?ulos-?1-?yl)?oxy]?-?2-?ethyl-?3,?4,?10-?trihydroxy-?3,?5,?8,?10,?12,?14-?hexamethyl-?11-?[[3,?4,?6-?trideoxy-?3-?(dimethylamino)?-?β-?D-?xylo-?hexopyranosyl]?oxy]?-?1-?oxa-?6-?azacyclopentadecan-?15-?one is an intermediate in synthesizing Tulathromycin A-d7 (T897152), a labeled analogue of Triamilide (T897150), an antibiotic for treatment of bovine and porcine respiratory disease. Exists as an equilibrium mixture of two isomeric forms, Tulathromycin A (90%) and B (10%). Antibacterial.

9-Deoxo-9a-aza-9a-homo 4’-Keto Erythromycin A Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global(7)Suppliers